Rokos Capital Management (UK)’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-687,318
Closed -$7.29M 102
2024
Q1
$7.29M Sell
687,318
-812,682
-54% -$7.11M 0.04% 75
2023
Q4
$12M Buy
1,500,000
+243,529
+19% +$1.77M 0.11% 46
2023
Q3
$10.4M Sell
1,256,471
-500,000
-28% -$4.31M 0.08% 70
2023
Q2
$14.1M Buy
+1,756,471
New +$12.9M 0.14% 50
2023
Q1
Sell
-1,028,019
Closed -$6.46M 61
2022
Q4
$6.46M Hold
1,028,019
0.28% 37
2022
Q3
$7.33M Buy
+1,028,019
New +$7.14M 0.22% 56

Other funds holding BHC

Rokos Capital Management (UK)'s BHC Position: Q2 2024 in Review

Rokos Capital Management (UK) sold out of Bausch Health (BHC) in Q2 2024, closing a stake of 687,318 shares — an estimated $7.29M sold.

Rokos Capital Management (UK) first reported a position in BHC in Q3 2022 and held it in 6 quarters. The position peaked at $14.1M in Q2 2023. 234 funds tracked by Wall St. Rank hold BHC as of Q2 2024.

  • Rokos Capital Management (UK) reported no remaining Bausch Health position as of Q2 2024 after selling out during the quarter.
  • Rokos Capital Management (UK) sold 687,318 Bausch Health shares in Q2 2024, an estimated $7.29M.
  • Rokos Capital Management (UK) first reported a position in Bausch Health in Q3 2022 and held it in 6 quarters.
  • Rokos Capital Management (UK)'s Bausch Health position peaked at $14.1M in Q2 2023.
  • 234 funds tracked by Wall St. Rank held Bausch Health as of Q2 2024.

Based on Rokos Capital Management (UK)'s 13F filing for Q2 2024, filed 14 Aug 2024.